Novartis India share news and announcements
NSE: NOVARTINDBSE: 500672Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,684.50.
- Next results date: the board meets on 3 Nov 2026 to consider: quarterly results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹4,505 Cr1,055th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 23 Jul 2026
- 46.1
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 12 May 2026
- 5.5
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 23 Jul 2026
- 12.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 23 Jul 2026
- 12.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 12 May 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,46,21823.7% delivered
Novartis India share news and announcements
606 announcements, routine notices left out, newest first. Page 2 of 13.
Jun 2026
11 Jun · Pre-Offer Advertisement & Corrigendum to Detailed Public Statement
4 Jun · Announcement under Regulation 30 (LODR)-Open Offer - Updates
4 Jun · Announcement under Regulation 30 (LODR)-Open Offer - Updates
May 2026
Apr 2026
1 Apr · Board meeting
Meeting on 12 May 2026: audited results
Mar 2026
27 Mar · Intimation Under Reg 30 Of SEBI LODR Of Receipt Of TDS Order As Per Income Tax Act
6 Mar · Intimation Of Receipt Of Draft Letter Of Offer Received From Manager To Open Offer (Axis Capital Limited).
6 Mar · Draft Letter of Offer
Feb 2026
26 Feb · Announcement under Regulation 30 (LODR)-Public Announcement-Open Offer
20 Feb · Open Offer - Public Announcement
20 Feb · Announcement under Regulation 30 (LODR)-Public Announcement-Open Offer
Jan 2026
Dec 2025
30 Dec · Board meeting
Meeting on 28 Jan 2026: quarterly results
Nov 2025
24 Nov · Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (The 'Listing Regulations')
Oct 2025
Sep 2025
30 Sep · Board meeting
Meeting on 28 Oct 2025: quarterly results
Aug 2025
Jul 2025
4 Jul · Business Responsibility and Sustainability Reporting (BRSR)